US Broker Ratings

Avanos Medical, Inc. (AVNS) Stock Analysis: Riding the Wave with a 52-Week High and Strategic Growth in Medical Devices

Avanos Medical, Inc. (NYSE: AVNS) is making waves in the healthcare sector with its robust presence in the medical devices industry. With a market capitalization of..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a 62.93% Upside Potential in the Biotech Sector

Pharvaris N.V. (NASDAQ: PHVS) stands out in the healthcare sector as a biotechnology firm focused on addressing rare diseases with a significant unmet need. With a..

Verastem, Inc. (VSTM) Stock Analysis: 158% Potential Upside Sparks Investor Interest

Verastem, Inc. (NASDAQ: VSTM), a biopharmaceutical company specializing in cancer treatment, is attracting attention from investors due to its significant upside potential. With a market capitalization..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Impressive Revenue Growth and Strategic Collaborations Signal Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the competitive biotechnology sector with its focus on developing and commercializing innovative medicines in the United States. With..

Sana Biotechnology, Inc. (SANA) Stock Analysis: A Promising 147% Potential Upside in the Biotech Sector

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering player in the biotech industry, is capturing investor attention with its robust potential upside of 147.02%. Specializing in cutting-edge..

Tilray Brands, Inc. (TLRY) Investor Outlook: Potential Upside of Nearly 48% Amid Diverse Product Portfolio

Tilray Brands, Inc. (NASDAQ: TLRY), a prominent player in the healthcare sector and a leader in the drug manufacturing industry, is a focal point for investors..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a 128% Potential Upside in Biotech Innovation

For investors with a keen interest in the biotechnology sector, Xencor, Inc. (NASDAQ: XNCR) presents a compelling opportunity, offering an impressive 128.25% potential upside according to..

Immatics N.V. (IMTX) Stock Analysis: A Biotech Gem with a 72% Upside Potential

Investors looking for promising opportunities in the biotechnology sector may want to consider Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company that is pioneering T cell..

STAAR Surgical Company (STAA)

⚠️ No article content returned.

..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 57.73% Potential Upside in the Medical Instruments Space

Embecta Corp. (NASDAQ: EMBC), a significant player in the healthcare sector’s medical instruments and supplies industry, offers an intriguing investment opportunity with its current market dynamics...

MeiraGTx Holdings plc (MGTX) Stock Analysis: A Promising 174% Upside in Genetic Medicines

MeiraGTx Holdings plc (NASDAQ: MGTX) is capturing the attention of investors with its strong potential upside in the realm of genetic medicines. As a clinical-stage biotechnology..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 136.90% Upside Potential

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services industry, offers a unique software-as-a-service (SaaS) healthcare commercial intelligence platform. This Massachusetts-based company,..

Stoke Therapeutics (STOK) Stock Analysis: Biotech Innovator with 27.62% Upside Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK), a cutting-edge player in the biotechnology sector, is capturing investor attention with its groundbreaking approach to addressing severe genetic diseases. With..

Sonida Senior Living, Inc. (SNDA): Investor Outlook Reveals Strategic Position in Healthcare Sector

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector, operates within the medical care facilities industry, specializing in providing a range of senior..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating the Healthcare Sector with a -16.37% Potential Downside

InnovAge Holding Corp. (NASDAQ: INNV) is a notable player in the healthcare sector, specifically in the medical care facilities industry. Based in Denver, Colorado, InnovAge is..

iRadimed Corporation (IRMD) Stock Analysis: Strong Buy Ratings and 29% Upside Potential

Investors eyeing the healthcare sector might find iRadimed Corporation (IRMD) an intriguing opportunity, given its specialized niche in the medical devices industry. With a market capitalization..

Oculis Holding AG (OCS) Stock Analysis: A Promising Biotech with a 74.79% Potential Upside

Oculis Holding AG (NASDAQ: OCS), a Switzerland-based clinical-stage biopharmaceutical company, is attracting significant attention from investors with its robust pipeline of drug candidates targeting ophthalmic and..

Orthofix Medical Inc. (OFIX) Stock Analysis: Evaluating a 39% Upside Potential Amid Industry Challenges

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, particularly in the medical devices industry, presents an intriguing opportunity for investors seeking exposure..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a 139.88% Potential Upside in the Biotech Arena

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company, is garnering significant attention in the investment community for its promising prospects in the biotechnology sector. Specializing..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds